Search

Cerus Corp

Open

SectorHealthcare

2.72 -0.73

Overview

Share price change

24h

Current

Min

2.7

Max

2.7800000000000002

Key metrics

By Trading Economics

Income

-1.3M

-3M

Sales

-2.5M

57M

EPS

-0.01

Profit margin

-5.191

Employees

261

EBITDA

-1.5M

-712K

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+64.23% upside

Dividends

By Acuity

Next Earnings

5 Nov 2026

Market Stats

By TradingEconomics

Market Cap

-73M

542M

Previous open

3.45

Previous close

2.72

News Sentiment

By Acuity

35%

65%

119 / 340 Healthcare

Cerus Corp Chart

Past performance is not a reliable indicator of future results.

Related News

21 Aug 2026, 19:26 UTC

Correlated Moves

Cerus Corp shares are higher, supported by gains in the healthcare sector and the ROBO Global Healthcare Technology and Innovation ETF.

20 Aug 2026, 19:26 UTC

Cerus Corp shares are lower today with no specific news identified. Broader market volatility continues amid rising crude oil prices.

19 Aug 2026, 19:26 UTC

Correlated Moves

Cerus Corp shares are higher today, supported by a rise in the ARK Genomic Revolution ETF. The stock remains above its 20-day moving average.

18 Aug 2026, 23:01 UTC

Cerus Corp shares are higher in after-market hours, supported by a significant increase in the Health Care Supplies sub-sector amid overall market gains.

17 Aug 2026, 19:26 UTC

Cerus Corp shares are lower today, retracing from earlier highs. The stock remains above its 20-day moving average after nine consecutive higher sessions.

14 Aug 2026, 19:13 UTC

Cerus Corp shares are trading higher during Friday's session, rebounding from an early decline amid notable volatility and increased market volume.

13 Aug 2026, 19:51 UTC

Macro Event

Cerus Corp is trading higher today, driven by a strong 30-Year Bond Auction yield. The stock has shown notable intraday volatility and high trading volume.

12 Aug 2026, 20:01 UTC

Cerus Corp shares are higher Wednesday, continuing a seven-session upward trend. Earlier, the stock pulled back from a session high.

11 Aug 2026, 20:02 UTC

Cerus Corp shares are gaining during Tuesday's session, with unusually high trading volume. No specific news has been identified to explain the movement.

10 Aug 2026, 20:02 UTC

Cerus Corp shares are higher today, following broader market gains since Friday amid tempered interest rate hike expectations from a recent labor market report.

7 Aug 2026, 23:56 UTC

Cerus Corp shares are higher in after-market trading, recovering from earlier declines amid shifting expectations for Federal Reserve interest rate hikes.

6 Aug 2026, 19:46 UTC

Cerus Corp shares are higher in Thursday's session, having gained since Wednesday. The stock remains below its 20-day moving average.

5 Aug 2026, 19:43 UTC

Cerus Corp shares are higher Wednesday, recovering from an earlier decline amid high trading volume. Broader market sentiment is influenced by ADP's employment report.

4 Aug 2026, 19:11 UTC

Correlated Moves

Cerus Corp shares are higher amid increased trading volume and positive market trends, despite concerns over declining U.S. core factory orders.

3 Aug 2026, 19:56 UTC

Correlated Moves

Cerus Corp shares are higher, supported by broader market strength and a rally in the health care supplies sector. The stock remains below its 20-day moving average.

31 Jul 2026, 23:06 UTC

Cerus Corp shares are higher in after-market trading, reflecting a notable increase since Friday's close, despite being below its 20-day moving average.

30 Jul 2026, 23:41 UTC

News

Cerus Corporation shares declined in after-market hours following a revenue miss and lowered full-year guidance, despite second-quarter earnings matching estimates.

29 Jul 2026, 19:56 UTC

Macro Event

Cerus Corp shares are lower as macroeconomic factors, including steady interest rates and rising oil prices, create market volatility. The stock is near its one-month low.

28 Jul 2026, 16:02 UTC

Cerus Corp shares are lower today, reflecting broader market pressures amid a risk-off sentiment following declines in tech-heavy indices like Japan's Nikkei 225.

27 Jul 2026, 20:07 UTC

Cerus Corp shares are higher in Monday's session, reaching a peak of 6.12%. Broader market factors include declining oil prices and lower Treasury yields.

24 Jul 2026, 19:06 UTC

Cerus Corp shares are higher, supported by a decline in crude oil prices that eased inflationary pressures. The stock remains below its 20-day moving average.

23 Jul 2026, 09:01 UTC

Cerus Corp shares are lower in pre-market hours, continuing a downward trend. The stock remains significantly below its 20-day moving average.

22 Jul 2026, 15:46 UTC

Cerus Corp. shares are trading roughly flat, with no specific news identified. The stock remains above its 20-day moving average after a month of gains.

21 Jul 2026, 21:41 UTC

Cerus Corp shares are lower in after-market hours, declining steadily after an early peak. No specific news was identified to explain the movement.

Peer Comparison

Price change

Cerus Corp Forecast

Price Target

By TipRanks

64.23% upside

12 Months Forecast

Average 4.5 USD  64.23%

High 5 USD

Low 4 USD

Based on 2 Wall Street analysts offering 12 month price targets forCerus Corp - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

2 ratings

2

Buy

0

Hold

0

Sell

Sentiment

By Acuity

119 / 340 Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Cerus Corp

Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion; and INTERCEPT Blood System for Cryoprecipitation that uses its plasma system to produce pathogen reduced cryoprecipitated fibrinogen complex for the treatment and control of bleeding, including massive hemorrhage associated with fibrinogen deficiency, as well as pathogen reduced plasma, cryoprecipitate reduced. It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. Cerus Corporation was incorporated in 1991 and is headquartered in Concord, California.
help-icon Live chat